Essentia Health Ada Clinic | |
201 9th St W Ada MN 56510-1279 | |
(218) 784-5000 | |
(218) 784-3753 |
Full Name | Essentia Health Ada Clinic |
---|---|
Speciality | Clinic/Center |
Location | 201 9th St W, Ada, Minnesota |
Authorized Official Name and Position | Alan Hurley (COO) |
Authorized Official Contact | 7013647667 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Essentia Health Ada Clinic 201 9th St W Ada MN 56510-1279 Ph: (218) 784-5000 | Essentia Health Ada Clinic 201 9th St W Ada MN 56510-1279 Ph: (218) 784-5000 |
NPI Number | 1366886186 |
---|---|
Provider Enumeration Date | 04/23/2013 |
Last Update Date | 02/29/2024 |
Medicare PECOS PAC ID | 4981659851 |
---|---|
Medicare Enrollment ID | O20050317000512 |
News Archive
Getting magnetic resonance imaging scans twice a year instead of one annual mammogram is far more effective at detecting early breast cancers in young women with a high-risk genetic profile than mammograms alone, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.
Swinging their arms helped participants in a new study solve a problem whose solution involved swinging strings, researchers report, demonstrating that the brain can use bodily cues to help understand and solve complex problems
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
A new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkinson disease.
From the removal of childhood birthmarks to skin rejuvenation, laser technology has become a mainstay in dermatology.
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1366886186 | NPI | - | NPPES |
635141700 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Getting magnetic resonance imaging scans twice a year instead of one annual mammogram is far more effective at detecting early breast cancers in young women with a high-risk genetic profile than mammograms alone, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.
Swinging their arms helped participants in a new study solve a problem whose solution involved swinging strings, researchers report, demonstrating that the brain can use bodily cues to help understand and solve complex problems
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
A new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkinson disease.
From the removal of childhood birthmarks to skin rejuvenation, laser technology has become a mainstay in dermatology.
› Verified 4 days ago